Monitoring the incidence, duration and distribution of hyperglycaemia in very-low-birth-weight newborns and identifying associated factors

• Published in: Journal of perinatal medicine Vol. 48; no. 6; pp. 631 - 637
• Main Authors: Fernández-Martínez, María del mar, Gómez-Llorente, José Luis, Momblán-Cabo, Jerónimo, Martin-González, Manuel, Calvo-Bonachera, María, Olvera-Porcel, María, Bonillo-Perales, Antonio
• Format: Journal Article
• Language: English
• Published: Germany De Gruyter 28.07.2020; Walter de Gruyter GmbH
• Subjects: Birth weight; continuous glucose monitoring system (CGMS); distribution; Glucose; Glucose monitoring; hyperglycaemia; Hyperglycemia; incidence; morbidity; mortality; Newborn babies; very-low-birth-weight infants; very-low-birth-weight infants; mortality; hyperglycaemia; continuous glucose monitoring system (CGMS); distribution; morbidity; incidence
• ISSN: 0300-5577; 1619-3997
• DOI: 10.1515/jpm-2020-0074

Objectives Hyperglycaemia is a common metabolic disorder in very-low-birth-weight (VLBW) infants and is associated with increased morbidity and mortality. The objective is to describe the incidence, duration, episodes and distribution of hyperglycaemia during the first 7 days of life of VLBW infants. Methods This is a prospective cohort study of 60 newborns weighing <1,500 g. Blood glucose levels were monitored with a continuous glucose monitoring system (CGMS) during the first 7 days of life. Hyperglycaemia was defined as glucose ≥180 mg/dL (≥10 mmol/L). Results Incidence of hyperglycaemia recorded with the CGMS was 36.6% (95%CI: 24.6-50.1). In almost 74.6±5.48% of these cases the duration of the episode exceeded 30 min and in 45.25% (95%CI: 2.26-57.82) it exceeded 2 h. The condition occurred most frequently during the first 72 h of life. One-fifth of cases were not detected with scheduled capillary tests and 84.6% of these had hyperglycaemic episode durations of 30 min or more. Agreement between the two techniques was very good (r=0.90, p<0.001) and the CGMS proved to be reliable, accurate and safe. Hyperglycaemia detected by a CGMS is associated with lower gestational age (OR: 0.66, p=0.002), lower birth weight (OR: 0.99, p=0.003), the use of ionotropic drugs (OR: 11.07, p=0.005) and death (OR: 10.59, p=0.03), and is more frequent in preterm infants with sepsis (OR: 2.73, p=0.1). No other association was observed. Conclusions A CGMS could be useful during the first week of life in VLBW infants due to the high incidence and significant duration of hyperglycaemia and the high proportion of cases that remain undetected. The advantage of the CGMS is that it is able to detect hyperglycaemic episodes that the capillary test does not.